AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
溫馨提示:AT7519,品質(zhì)穩(wěn)定,純度>98+%,僅供實驗使用.產(chǎn)品質(zhì)量嚴(yán)格控制,保證品質(zhì)。
南京百鑫德諾生物科技有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!